UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 1618, 2026

DuPont de Nemours, Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-38196	81-1224539
(State or other jurisdiction of incorporation)	(Commission file number)	(IRS Employer Identification No.)

974 Centre Road,

Building 730

Wilmington,

Delaware

19805

(Address of Principal Executive Offices)

(Zip Code)

(302) 295-5783

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐☑ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Section 78 - ~~Fair~~Other ~~Disclosure~~Events

Item 78.01 Other ~~- Regulation FD Disclosure~~Events.

On March 18, 2026, DuPont de Nemours, Inc., a Delaware corporation (the “Company” or “DuPont”), ~~expects~~issued a press release announcing that it plans to ~~close~~seek approval for an amendment to the ~~previously~~Company’s ~~announced~~Third ~~sale~~Amended ofand ~~its~~Restated ~~aramids~~Certificate ~~business~~of Incorporation (~~Kevlar®~~the ~~and~~“Certificate ~~Nomex®~~of Incorporation”) to ~~Arclin1~~effect, onat ~~April~~the 1discretion of DuPont’s Board of Directors (the “Board of Directors”), ~~2026~~a reverse stock split of the Company’s common stock, par value $0.01 ~~All~~per ~~regulatory~~share, ~~conditions~~at a ratio of not less than 1-for-2 or more than 1-for-4, with the exact ratio to ~~close~~be determined by the ~~sale~~Board ~~transaction~~of ~~were~~Directors ~~satisfied~~at a later date. The press release is attached hereto as ofExhibit ~~March~~99.1 ~~10,~~and ~~2026~~is incorporated herein by reference.

~~The~~DuPont’s ~~information~~Board ~~contained in Item 7.01~~ of ~~this~~Directors ~~report~~has isset ~~being~~March ~~furnished~~30, ~~and~~2026 ~~shall~~as ~~not~~the berecord ~~deemed~~date ~~filed~~ for ~~purposes~~stockholders ofentitled ~~Section~~to 18vote ofat the ~~Securities~~Annual ~~Exchange~~Meeting ~~Act~~ of ~~1934,~~Stockholders ~~as amended~~ (the “~~Exchange~~Annual ~~Act~~Meeting”),. orThe ~~otherwise~~time ~~subject~~and toother ~~the~~details ~~liabilities~~regarding ofthe ~~Section~~Annual 18Meeting ofwill ~~the~~be ~~Exchange~~communicated ~~Act.~~to ~~Furthermore,~~stockholders ~~the~~at ~~information~~a ~~contained~~later indate ~~this~~via ~~report~~preliminary ~~shall~~proxy ~~not~~materials bewhich ~~deemed~~will to be ~~incorporated~~filed bywith, ~~reference~~and ~~into~~will ~~any~~be ~~registration~~subject ~~statement~~to orreview ~~other~~by, ~~document filed pursuant to~~ the U.S. Securities ~~Act~~and ofExchange ~~1933,~~Commission ~~as amended, or~~ (the ~~Exchange Act~~“SEC”).

Solicitation Material

This communication may be deemed to be solicitation material in connection with the proposal to be submitted to DuPont’s stockholders at its Annual Meeting seeking approval of an amendment to the Certificate of Incorporation to effect a reverse stock split. In connection with the proposal, DuPont plans to file a preliminary proxy statement on Schedule 14A with the SEC. The Company expects to file its definitive proxy material in due course. Stockholders are encouraged to read the preliminary proxy statement and all other relevant documents filed with the SEC when they become available, including the definitive proxy statement, because they will contain important information about the proposal. Stockholders may obtain a free copy of the proxy statement and other documents that the Company files with the SEC at the SEC’s website (www.sec.gov) or from the Company by accessing information included on the Investor Relations website (investors.dupont.com).

Section 9 - Financial Statement and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits


Exhibit Number
99.1			Press release issued by DuPont de Nemours, Inc. on March 18, 2026 announcing the reverse stock split proposal.
104			The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

Cautionary Statement Regarding Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “see”, “will”, “would”, “target”, “outlook”, “stabilization”, “confident”, “preliminary”, “initial” and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the ~~expected~~ timing, ofratio, ~~the~~completion, ~~closing~~and benefits of the ~~sale~~reverse ~~transaction~~stock split. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont’s control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont’s filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, subsequent quarterly reports on Form 10-Q and other filings. Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion (if at all), account and tax treatment of the proposed transaction including (x) any failure to satisfy any of the other conditions to the proposed transaction, (y) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction, and (z) risks and costs and pursuit and/or implementation, timing and impacts to business operations of the separation of business lines in scope for the proposed transaction; (ii) the impact of the proposed transaction and ownership of a minority interest in the future Arclin company on DuPont’s results of operations; (iii) other risks to DuPont’s business and operations, including the risk of impairment; and (iv) other risk factors discussed in DuPont’s most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

1 ARC Falcon Holdings, L.P., a Delaware limited partnership (“Holdings”) and New Arclin U.S. Holding Corp., a Delaware corporation and wholly-owned subsidiary of Holdings.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DUPONT DE NEMOURS, INC.

Registrant

Date:

March 1618, 2026

By:

/s/ Erik T. Hoover

Name:

Erik T. Hoover

Title:

Senior Vice President and General Counsel

Filing Compare · DuPont de Nemours, Inc.